Latest Articles
Organon to halt development of endometriosis pain drug after mid-stage trial failure - whbl.com
Organon to halt development of endometriosis pain drug after mid-stage trial failure whbl.com
Published: July 2, 2025, 9:02 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits - Investing.com India
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits Investing.com India
Published: July 2, 2025, 5:15 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results - Stocktwits
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results Stocktwits
Published: July 2, 2025, 4:43 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results - MSN
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results MSN
Published: July 2, 2025, 3:55 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Nigeria
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Nigeria
Published: July 2, 2025, 12:52 p.m.
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener
Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada
Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada
Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener
Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener
Organon abandons endometriosis pain drug development after trial failure MarketScreener
Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com
Organon halts development of endometriosis pain drug after trial failure Investing.com
Published: July 2, 2025, 11:42 a.m.
Link copied to clipboard!